Endocrinology
31 - 44 of
44 Results
Sort Results:
Article:
Sliding scale insulin is still giving patients a ride on the blood glucose roller coaster
January 2014
Article:
Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes
November 2013
Article:
Nesina (nes-SEE-na, alogliptin) will compete for your prescription in a crowded market of gliptins for type 2 diabetes
August 2013
Article:
Invokana (in-vo-KAHN-uh, canagliflozin), the first in a new class of oral drugs for type 2 diabetes
May 2013
Guideline:
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012)
November 2006